首页> 美国卫生研究院文献>Experimental Diabetes Research >The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
【2h】

The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control

机译:1型糖尿病患者血管内皮生长因子循环血浆水平升高与代谢控制无关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aim. To characterize the plasma levels of vascular endothelial growth factor (VEGF) in type 1 diabetes mellitus (T1D) and its relation to both present and historical metabolic control and microvascular complications. Methods. Plasma levels of VEGF and routine clinical parameters were analyzed in 115 patients with long-standing T1D and 45 healthy controls (HC). All patients were under clinical routine diabetes treatment at Uppsala University Hospital. Results. The plasma levels of VEGF were increased by 37% in patients with T1D when compared to HC (18.2 ± 0.8 versus 13.2 ± 1.0 pg/ml, p < 0.001). The levels of VEGF correlated to insulin needs and BMI but not to present or historical metabolic control. The levels of VEGF were similar in patients with T1D and microvascular complications (microalbuminuria and retinopathy) when compared with patients without microvascular complications. Historical HbA1c levels were found to be the best predictor for present metabolic control. Conclusion. Circulating plasma levels of VEGF do not correlate to present or historical metabolic control in long-standing T1D and the levels are not affected by the presence of microvascular complications.
机译:目标。表征1型糖尿病(T1D)中血管内皮生长因子(VEGF)的血浆水平及其与当前和历史代谢控制以及微血管并发症的关系。方法。在115位长期存在T1D的患者和45位健康对照(HC)中分析了血浆VEGF水平和常规临床参数。所有患者均在乌普萨拉大学医院接受临床常规糖尿病治疗。结果。与HC相比,T1D患者的血浆VEGF水平增加了37%(18.2±0.8对13.2±1.0μpg/ ml,p <0.001)。 VEGF的水平与胰岛素需求和BMI相关,但与当前或历史的代谢控制无关。与没有微血管并发症的患者相比,患有T1D和微血管并发症(微白蛋白尿和视网膜病变)的患者的VEGF水平相似。发现历史HbA1c水平是目前代谢控制的最佳预测指标。结论。在长期的T1D中,循环血浆VEGF的水平与当前或历史的代谢控制无关,并且该水平不受微血管并发症的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号